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THE HLA-E GENE ENCODES TWO DIFFERENTIALLY REGULATED 
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An  HLA-E-specific  oligonucleotide  probe  was  used 
to study  the  expression of HLA-E. This  probe detects 
two HLA-E transcripts, 1.8 and 2.7 kb  in size, which 
are  present  in  varying  ratios  in  all tissues and cell 
lines investigated. We demonstrate  that  alternative 
poly(A) site usage  accounts for the  differential  reg- 
ulation of the  two HLA-E mRNA species. Sequence 
analysis of three cDNA clones, representing  the  two 
transcripts of HLA-E, and  of  an HLA-E gene  encoded 
by cosmid cd3.14, revealed identity of gene and 
cDNA in the 3’ untranslated region. S1 nuclease 
protection assays confirmed that the two HLA-E 
transcripts are not alternative splicing products. 
Introduction of cd3.14, together with human ,&m 
into  the murine  myeloma cell  line  P3X63-Ag8.653, 
resulted  in  a  cell  surface  expression of a  HLA-class 
I heavy  chain  detectable by indirect  immunofluores- 
cence whereas  transfection  into  the  human Bzrn ex- 
pressing  mouse L cell line, 527 was  negative  with 
regard to cell  surface  expression. Cell surface  label- 
ing of transfectants and  immunoprecipitation  with 
a monomorphic HLA class I-specific  antibody or an 
antibody against human &m confirmed the pres- 
ence of an HLA-E H chain  on  the  cell  surface.  These 
results indicate that the HLA-E gene codes for a 
class I H chain  that  can be expressed  on  the  cell 
surface. 
The  human MHC class I gene  cluster located on the 
short  arm of chromosome 6 comprises at least  17  genes, 
pseudogenes,  and  gene  fragments (1). Among these, only 
the highly  polymorphic,  ubiquitously  expressed  classical 
class I loci HLA-A, -B, and -C encode  serologically defined 
cell surface  glycoproteins of approximately 44 kDa that 
are noncovalently associated with invariant &m3 and 
that  constitute  the  restriction  elements  for  virus-specific 
and allospecific CTL. The  function of nonclassical  class 
I genes is not  clear so far. However, it has  been proposed 
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that  in  the  mouse  some  non-H-2  class I Ag may  have a 
function  in  self-tolerance  and T cell restriction  (2).  Study- 
ing  the  contribution of the  human non-HLA-A, -B, and - 
C class I gene  products (HLA-E and HLA-F) to cellular 
immunity  has been  hampered by the lack of efficient cell 
surface  expression  upon  transfection (3 ,  4).  Therefore, a 
knowledge of the  tissue specificity of transcription  and 
of the regulation of cell surface  expression  may be  helpful 
in  elucidating  their possible physiologic functions. 
Like the classical MHC class I loci, the HLA-E gene is 
highly transcribed in many tissues (4-6), but displays 
only  little  genetic  variation.  Several  groups  have isolated 
HLA-E-derived sequences  that differ by few  amino  acids 
(4. 5, 7-12).  Conflicting results  have  been  obtained con- 
cerning  the cell surface  expression of the HLA-E-encoded 
class I heavy  chain. Upon transfection of a 6.2-kb Hind111 
HLA-E subclone  into a n  HLA class I negative mutant B- 
LCL, only a n  intracellular  41-kDa H chain could be co- 
precipitated  with P2m (3 ,  4). In contrast,  the  transfer of a 
16-kb EcoR I subclone  containing  another HLA-E gene, 
was reported  to give rise  to  detectable  surface  expression 
when transfected into mouse L cells that  also  express 
human  &m (8). The  controversial  results  concerning cell 
surface  expression of HLA-E led us to  introduce a gen- 
omic  cosmid as well a s  a cDNA clone of  HLA-E into  mouse 
cell lines  and  to  test  stable  transformants  for  the  pres- 
ence of  HLA-E  mRNA and cell surface  expression. 
Inasmuch as Northern blot analysis revealed  two tran- 
scripts of HLA-E in all cell lines  and  tissues  analyzed, we
wondered whether  they might  encode  different  transla- 
tion products. Therefore, we isolated cDNA clones and 
performed S1 nuclease  protection  experiments to deter- 
mine  the  nature of the HLA-E transcripts. 
MATERIALS AND METHODS 
Tissue  culture.  human cell lines.  and  stimulation, All cells  were 
cultured in RPMI 1640 supplemented with 10% FCS, 2% L-gluta- 
mine,  and 1 % penicillin/  streptomycin  (all GIBCO. Grand  Island, NY). 
with  the  exception of the L  cell line,  527  which was maintained  in 
DMEM HAT medium  supplemented  with 10% FCS, 2% L-glutamine. 
and 1% penicillin/streptomycin. The following human cell lines  were 
used  in  this  study:  the B-LCL. LG2 (HLA-type: -A2, -B27. -Cwl) (131, 
TY (A1 1, -B35,  -Cw4). and KR (-A2,  -B44, -Cw5). RaDa  and  KaFraDa 
(both HLA-B27+). the melanoma cell line Me1 Juso, the chronic 
myelogenous leukemia cell line K562, the cervix epitheloid carci- 
noma cell line HeLa and  the colon carcinoma cell line  SW480. T-AI1 
are PBL  of a patient  suffering  from  acute T lymphatic  leukemia.  The 
cell lines m.m. and m.c. have been established by Dr. I. Funke, 
Munich. F.R.G. from bone marrow micrometastases of a patient 
with breast carcinoma (m.m.1 and colon carcinoma (m.c.), respec- 
tively. 
The 4 to 5 X 106/ml K562  and  SW480  cells  were  stimulated  with 
1000 U/ml of human rIFN-7 (Boehringer  Mannheim.  Indianapolis, 
IN) for 48 and  24  h.  respectively. 
PBL were  isolated and  cultivated  according  to  standard protocol. 
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PHA (Sigma) was added at  a concentration of 2 pg/ml. After incu- 
CHX (Sigma) was added at  a concentration of 10 Wg/ml (2  h)  to one 
bation  for  2 days,  the PBL culture  was split into two fractions  and 
fraction. 
Murine cell lines and transfection. The L cell line, 527 (14). 
which expresses  human &m was  transformed by the calcium  phos- 
phate-mediated DNA transfer  technique  with  either cosmid cd3.14 
or the expression cDNA construct, pLG2-C1/KSVneo. both clones 
carrying  the AGPT gene. Transformants were  selected and grown in 
DMEM HAT with 1 mg/ml G418 (GIBCO). The mouse myeloma cell 
line  P3X63-Ag8.653  (X63) was  cotransfected by electroporation (1 5) 
hm-gene  in pUC18 (16) together with either a Sal1 linearized 6.3-kb 
with  a  BamH I linearized 15-kb BamH ]/Sal1 subclone of the  human 
EcoR I/BamH I subclone of the cosmid cd2.6 (1  7)  in pTM or with  the 
ClaI linearized cosmid cd3.14. the latter both carrying the AGPT 
gene. Transfected cells were selected and grown in RPMI 1640 
containing 1 mg/ml G418 (GIBCO). 
Monoclonals. Hybridomas producing mAb specific for human &m 
class I heterodimers, B9.12.1(16). W6/32. and TM3 ( 18):  human Pzm. 
RBM.1:H-2Kk. 141-11,andH-2Dd,34-4-21S(19)werekindlymade 
available by the respective  laboratories. The mAb specific  for human 
class I H chain, A1.4 ((20): United Biomedical Inc.,  Hauppauge, NY) 
and  human CD4, M-T242 were used as purified antibody. 
Indirect immunofluorescence. The 4 x lo5 cells  were incubated 
with 40 p1 of hybridoma supernatant or Al.4  at a concentration of 
20 pg/ml for 30 min  on ice. Cells were  washed twice with PBS and 
then  incubated with 41) pl dichlorotriazinyl aminofluorescein goat 
anti-mouse Ig (Dianova,  Hamburg, F.R.G.) a t  a concentration of 25 
pg/ml for 30 min on ice. After four  washes with PBS. samples were 
fixed with  1 % paraformaldehyde in PES and analyzed  on a FACScan 
flow cytometer (Becton Dickinson,  Mountain View, CA). 
Isolation of cd3.14, LGZ-CI,-EI, and -E2. A genomic cosmid 
library  (cd) established from PBL  of a healthy donor (HLA-type: -A2, 
the HLA-B  cDNA probe pB1 (13). Eleven distinct  class I genes were 
-B27/-B5 1, -Cw2/-Cw3) ( 17)  was  screened for class I+ clones  with 
rescreened  using  the oligomer oLG2-C1 (aa  143  to  153, 33 bp): 5’- 
CGC CTC AGA GGC ATC ATT TGA CTT TTG CTC GGA-3’, unique 
for the HLA-E sequence, which hybridized only to cosmid cd3.14. 
Although the HLA-E allele encoded by cosmid cd3.14  carries a silent 
substitution in the triplet aa 150. GCT instead of  GCC. the length of 
33 bp of the oLG2-C1 oligonucleotide explains why this difference 
was  not discriminated at  the hybridization and  washing conditions 
applied. The isolation of LG2-C1 from a cDNA library constructed 
from the homozygous B-LCL  LG2 ( 13)  has been  described  elsewhere 
(7).  The clones LG2-E1 and LG2-E2 were obtained from the  same 
cDNA library  using a 3’  2.8-kb BamHl fragment of cd3.14 as the 
probe (Fig. 2). By in vitro mutagenesis  and  several  subcloning  steps. 
the incomplete 5‘  end of the LG2-C1 cDNA was replaced by the 5’ 
flanking  and exon 1 sequence of an HLA-B8  cDNA (7)  and subcloned 
as BamH I fragment  into  the BgllI site of the eucaryotic  expression 
vector pKSVlO (Pharmacia Fine Chemicals, Piscataway, NJ). The 
nucleotide sequence of the  generated  5’  end, including the codon for 
the  first  amino acid residue of the  mature protein, is: 
GGATCCACCCTTAAGATA  ATG CTT GTG GGG GCG  CGC  CGA  ACC 
G T C C T C C T G C T G C T C T C G G G A G C C C T G A C C G A G A C C T G G  
GCC  TGG  GCG  GGC. A s  a  selection marker, a  BamHIISalI fragment 
containing  the AGPT gene,  was  inserted into the BamHIISalI sites 
of this  subclone,  generating pLG2-C1/KSVneo. 
clones or the 2.8-kb BamHI fragment subcloned into Bluescript 
DNA sequence analysis. DNA sequence analysis of M13 sub- 
(Stratagene. La Jolla. CA) was performed  according to the  sequencing 
strategy depicted in  Figure 2. The region carrying exon 2 and 3 of 
cosmid cd3.14  was directly  sequenced using  the  primers described 
by ( 10)  and oLG2-C 1. Dideoxy chain  termination method was applied 
using  the  T7  sequencing kit of Pharmacia. 
Southern and Northern blot analysis.  Southern blot analysis of 
genomic DNA isolated from various HLA haplotypes was carried  out 
according to a standard protocol. Probes were labeled by the random 
primer method (21) with [a-32PjdATP (Amersham Corp.. Arlington 
Heights, IL) and hybridization was performed  according to the 
method of Church  and Gilbert (22). Purification of the 33 mer oLG2- 
C1 and hybridization at  65°C were performed as described (23).  The 
probe was labeled with terminal desoxynucleotidyl transferase 
(Boehringer Mannheim, Indianapolis, IN) and [ C Y - ~ ~ P ~ ~ A T P  (Amer- 
sham]  (24).  Washing  was done at  65°C  with 3x SSC, 10 mM NaHZPO4/ 
NaZHPO4, lox  Denhardt’s, 5% SDS for 2x 20 min and with l x  SSC, 
1% SDS for 10  min. 
RNA from human  tissue, cell lines,  and PBL was prepared by the 
procedure of Chirgwin et  al.  (25). A total of 10  to  20 pg of total RNA 
was separated on formaldehyde agarose gels and transferred to 
Hybond-N membrane  (Amersham).  The  filters were hybridized with 
the  3’  2.8-kb BamHl fragment of cd3.14, a 3’ UT 450-bp HLA-B- 
specific  PstIlPuulI  probe  (1 3) and a 2.8-kb  human PZm specific BglII 
fragment  (16). Hybridization with oLG2-C1 and with the c-fos-spe- 
cific oligomer c-fos/ol (aa 4-24. 60 bp): 5°C CCC GGC CGG GGA 
CGCGCTGCTGCAGCGGGAGGAGTACGCCTCGTAGTCGTT 
GAA GC-3’ and  subsequent  washing were performed as  described 
above at  65°C. 
Generation of single  stranded  probes by PCR (Fig. 5B). Linear 
PCR amplification of 50 ng of a subclone of LG2-C1 in pUC18, 
digested with EcoR I .  was performed  in 10 cycles successive to an 
initial denaturation  step  at 94°C for 2  min with  the following con- 
ditions: 94°C (2  min)  and 72°C (2  min):  the  last extension  reaction 
(72°C) was extended  for 5 min.  The reaction was primed with 30 ng 
of purified oligonucleotide oLG2-C1 generating a single stranded 
antisense probe, 534 nucleotides  in length. 
A total of 50  ng of the  same subclone, digested with AuaI1, was 
amplified in 10 cycles succeeding an initial denaturation step at  
94°C for 3 rnin adopting the  subsequent conditions: 94°C (1  min). 
56°C (1  min),  and 72OC (2.5 rnin): the  last extension  reaction (72°C) 
was 5 min. As primer 25  ng of a 21 mer located at  the  3‘  end of exon 
4 (aa 262-269: 5’GCT CGG GTA GCC CCT CAT GCT 3’)  was used. 
The size of the single stranded  antisense probe was 404 nucleotides. 
PCR amplification (26)  was carried  out in  20 p1 of a  buffer containing 
50 mM KCl, 10 mM Tris-CI, pH 8.3, 1 mM Mg2C1, 100 pM dGTP and 
32P]dCTP (both Amersham 370 MBq/ml, 3.33 pM) with 1.25 U Taq 
dTTP, 90 pM dATP and dCTP, and 3 pl each of [cY-~’P]~ATP  and [a- 
polymerase  (Boehringer-Mannheim)  in  a PCR Thermal Reactor (Hy- 
baid,  Teddingbon. U.K.). 
The probes  were  passed over a  Sephadex G50 spin column and 
purified by electrophoresis through a 4% polyacrylamide/7 M urea 
gel. The  bands of the correct  size  were excised and eluted at 37°C 
for 3 h  in 500 pl 500 mM ammonium  acetate,  0.5% SDS, and 1 mM 
EDTA. After a  phenol/chloroform  extraction step,  three aliquots of 
described below. 
each probe were precipitated with 30 pg of the RNA preparations as 
SI  nuclease  protection  assays. The  conditions  for hybridization 
and  S1 nuclease digestion were as  described (27) with the following 
modifications. Three 30-pg samples of each total RNA were  hybrid- 
ized overnight with equal aliquots of either of the continuously 
Digestion was performed at 32°C for 2 h with 600, 1200. or 2400 U 
labeled probes (sp.  act. -10’ cpm/pg) in a volume of 20 pl a t  32°C. 
of S1 nuclease  for each  assay.  The protected DNA was precipitated 
and redissolved in 4 p1 of 10 mM Tris-U. pH 8.0, 1 mM EDTA. pH 
8.0,  and analyzed by electrophoresis through a 4% polyacrylamide/ 
7 M urea gel. 
cDNA synthesis  and PCR. For first  strand cDNA synthesis 2 pg 
of total RNA were denaturated 3 min at  94°C  in 5 pl  of 5 mM Tris- 
HCI, pH 8.3,  75 mM KCl. 3 mM MgCl2. 10 mM dithiothreitol plus  12 
ng/ml oligo dT. After an annealing step for 10 min at  50°C the 
reaction volume was raised to 10 pl with the  same  buffer  plus 5 pM 
dNTP, and  200 U of Moloney murine leukemia virus reverse tran- 
scriptase (Gibco BRL, Gaithersburg, MD), and cDNA synthesis  car- 
ried out for 60 min at  37°C. Each cDNA reaction sample  was diluted 
1/3  and 1 p1 was amplified in 20 pl PCR buffer  (50 mM KCl. 10 mM 
Tris-C1. pH 8.3, 1 mM MgClZ). 100 pM dNTP. 1.25 U Taq polymerase 
(Boehringer-Mannheim) and 50 ng  each of the amplification primers 
P1 and P2 (Fig. 6). P1 ( 5’-CAG CAT GAG GGG CTA CCC (2-3’) is a 
TGA  GGA AGG GGG TCA TG-3’) is an  antisense oligo derived from 
sense oligo specific  for the 3’end of the exon 4 of HLA-E.  P2 (5”GTG 
the  3’untranslated region of the HLA-E mRNA. The following am- 
plification was adopted using a PCR Thermal Reactor (Hybaid): 5 
min. 94°C: 10 cycles: 1  min 94°C. 1  min 50°C 1 min 72°C: 40 cycles: 
1  min 9 4 T ,  1  min 55°C 1  min 72°C: 10 min 72°C. The PCR products 
were  analyzed  on  a 1.5%  agarose gel containing ethidium bromide. 
faces was carried out using the lactoperoxidase-glucose oxidase 
Preparation of radiolabeled  proteins.  The iodination of cell sur- 
method (28). In brief, 3 x lo7 cells cultured at 37°C were washed 
twice with PBS and labeled in  1 ml of PBS with 5 U lactoperoxidase 
(Sigma. L-0515).  6 U glucose oxidase type V (Sigma), and 1 mCi of 
carrier free Na Iz5I (17.4 Ci/mg: Du Pont. Wilmington. DE) in the 
presence of 0.01 mM KI and 5 mM o-glucose for 20 min at  room 
temperature. Cells were washed five times in PBS/10% FCS and 
lysed. 
Immunoprecipitation and SDS-PAGE. Cells were lysed at  4°C for 
30 min in  0.6 ml lysis  buffer (1% (w/v) Nonidet-P40, 2 mM benza- 
midine HCl. 2 mM PMSF, 2% (v/v) aprotinin in PBS). After sedimen- 
tation of nuclei and  debris  at  15,000 x g  for 15  min  at 4”C, lysates 
were suppemented with 100 pl of FCS and precleared at  4°C 5 x 12 
h  with 100 pl horse  serum  saturated  Sepharose 6B (Pharmacia)  and 
2  x 12 h  with 50 pl of protein A-Sepharose CL-4B (Sigma). 
4°C) using the following reagents: 20 @I isotype control M-T242- 
L251-labeled proteins were sequentially  immunoprecipitated (1 h at 
protein  A-Sepharose, 20 pl of A1.4-protein A-Sepharose and finally 
were cleared  with 20 pl  of protein A-Sepharose  for  2  h at 4°C. 
20 pl of BBM.l-protein A-Sepharose. Between each round lysates 
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(w/v)  Nonidet-P40.  resuspended  in 50 pl of SDS sample  buffer-(4.2% polymorphism. 
SDS. 0.1% 2-ME, 18% glycerol), boiled for 3 min. and analyzed by 
SDS-PAGE on 10% gels. HLA-E gene transcription does not display  t sue 
restriction. Northern blots hybridized with HLA-E 
v v 
RESULTS subfragments revealed two transcripts  (4. 5. 12). To in- 
Invariant structure of HLA-E gene. Comparison of the 
sequence of the HLA-E cDNA clone LG2-Cl (7) to the 
classical HLA-A, -B, and -C genes reported to date, 
showed the greatest divergence to be clustered in a 
stretch of DNA encoding the  amino acid residues 143 to 
153. To study HLA-E gene  expression, an oligonucleotide 
oLG2-C1 corresponding to this region was synthesized 
and shown to be strictly  specific  for the HLA-E gene  in 
Southern blot analyses of genomic DNA restricted  with 
BglII and PstI, which give rise to fragments  characteristic 
of HLA-E (Fig. 1).  This oligomer also identified a cosmid 
cd3.14 isolated from the cd library  (1 7). established from 
PBL of a healthy  donor,  to  contain an  HLA-E gene. This 
assignment was confirmed by Southern blot and se- 
quence  analysis. Cosmid cd3.14  encodes  the HLA-E al- 
lele, E*0105 (EMBL: X64880)  with Gly at  aa positions 83 
and  107 compared  to the HLA-E allele EIOlO2. encoded 
by  HLA-6.2 (4,  11)  and a silent  substitution  in  the  triplet 
for aa 150. GCT instead of GCC. The restriction map of 
cd3.14 differs from that of the HLA-6.2 allele by a 3' 
BarnHI restriction  site and from the HLA-E gene encoded 
by cosmid RS5 (8. 9) by a PstI  (aa 95) and a BglII site 
(3'untranslated region) within  the HLA-E gene,  in  addi- 
tion to sites upstream and downstream of the coding 
region (Fig. 2).  Southern blots of PstI, BglII. and BarnH I 
digested genomic DNA from various  donors  with  different 
haplotypes hybridized with either oLG2-Cl (Fig. 1). or 
with subfragments of the HLA-E  cDNA clones (Fig. 2).  a 
3' 950 bp PstI fragment of LG2-C1 (data not shown) or 
with  a  400-bp PstIIPvuII fragment of the LC2-E2 cDNA 
clone (data not shown) confirmed the restriction map of 
PSI I ngr I! 
"
3 4-4 .5  kb 
1.1 kb+ .. - -. . 
1 2 3 4 5 6  
Flgure 1 .  Southern blot analysis confirms the organization of the 
HLA-E gene. Genomic DNA isolated from PBL (DH. LK. E W )  of donors 
with various HLA haplotypes and from B-LCL (LG2. RaDa. KaFraDa) 
sharing the B27 allele. w2s digested with Pstl  and Bglll. generating 
fragments unique to the HLA-E gene. and probed with oLG2-C 1. 
vestigate the  tissue expression of  HLA-E  mRNA and  the 
ratio of the two transcripts, an antisense oligomer, oLG2- 
C1. specific for both mRNA, was used. Considerable 
amounts of two transcripts of HLA-E of 1.8  and 2.7 kb, 
respectively, were detected in  various human cell lines of 
different  origins and  human  tissues (Figs. 3, 5A and 7). 
The  tissue  distribution of  HLA-E  mRNA is not restricted 
and  thus, resembles the expression pattern of the clas- 
sical HLA-A/-B/-C genes and also  the  amount of  HLA-E 
transcripts is similar (Fig. 3). Even in unstimulated 
chronic myelogenous leukemia, K562 cells, known to be 
MHC class I-, HLA-E mRNA can be detected after pro- 
longed exposure of autoradiographs (Figs. 3. 5A. and 8a) 
(5). Interestingly. also in placenta more HLA-E mRNA 
was  present than HLA-A or HLA-B. In all fresh  tissues 
analyzed the larger transcript seemed to predominate 
with the exception of the lung,  where the ratio of the two 
mRNA species was about one to one. In the cell lines 
examined  to date, we found at least  equivalent amounts 
of the two messages with a prevalence of the smaller 
transcript, except in T-ALL cells (PBL  of a patient  suffer- 
ing from acute T  lymphatic  leukemia), in the cervix epi- 
theloid carcinoma cell line, HeLa (Fig. 5A). and in the 
colon carcinoma cell line  SW480 (Fig. 7B). Upon stimu- 
lation of PBL with PHA (Fig. 7A), an overall increase of 
HLA-E  mRNA and a shift from the large transcript to the 
smaller mRNA was observed. This  was also  seen in the 
cell line  SW480  treated  with IFN-7 (Fig. 7B).  This  differ- 
ential  enhancement of the two HLA-E  mRNA seems not 
to be a common feature of  HLA-E induction.  since K562 
cells stimulated with IFN-7 (Fig. 5 A )  showed an equal 
increase of both transcripts. 
Two HLA-E transcripts only differ in extent of 3'UT. 
It was of interest to determine  whether  the differential 
regulation of HLA-E transcripts might be important  in 
the control of cell surface expression of  HLA-E Ag. 
whether only the larger transcript is functional, and 
whether  alternative  splicing might produce a different 
translation  product. A 3' 2.8-kb BarnH I fragment from 
cd3.14 (Fig. 2) hybridized exclusively to the large tran- 
script  (data  not  shown)  and  was used to isolate the cDNA 
clones LG2-E1 (Figs. 2 and  4)  and LG2-E2 (Fig. 2. codes 
for the  sequence  848 to 1557 bp, Fig. 4) from the LG2 
library,  established from the B lymphoblastoid cell line 
LG2 (1 3). Sequence  analysis of LG2-E1 (-E2) as well as  of 
the 3' region of cd3.14 revealed identity of the cDNA and 
the genomic sequences (Figs. 2 and 4). Two differences 
were found  in LG2-E1 that might be explained by a cDNA 
cloning artefact (Fig. 4). No alternative  splicing in the 3' 
region was detected. A third polyadenylation signal is 
present 850 bp  down-stream of two immediately adjacent 
sites  and is used in the 2.7-kb transcript (Fig. 4). A partial 
HLA-E  cDNA clone,  similar  to  LG2-El.  E015, presumed 
to be derived from the  2.7-kb HLA-E  mRNA, has recently 
been cloned from blood eosinophils (12). Several base 
substitutions  are  present when  comparing  our  sequences 
to  E015. The length of these cDNA confirm the size of 
2.7 kb measured for the larger transcript. 
Inasmuch as  no full length cDNA clone coding for the 
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Flgure 2. Restrlctlon map of cosmld clone cd3.14 and cDNA clones LG2-CI. LG2-El. and LC2-E2. The gene carrylng region Is shown as a blow- 
up. Shaded  boxes numbered below  Indicate the coding exons 1-7. The 3' UT Is depicted as open  box.  pA designates the polyadenylatlon slgnals. The 
sequencing strategy Is indlcated by arrows. Restrlctlon endonucleases  sites wlth uncertain relative posltlons to each other are deslgnated by asterlsk. 
The orlgln and the locatlon of the probes used in thls study are lndlcated by hatched  boxes. 
1 2  3 4 5 6 7 8 9 1 0 1 1 1 2 1 3  
U 
Figure 3. Detectlon of HLA-E mRNA  by northern blot analysis. A total 
of IO pg of total RNA per lane were separated on a formaldehyde agarose 
gel and probed wlth elther oLC2-CI (a)  or wlth the  3' UT 450-bp HLA-B- 
specific Puull/Pstl probe (b ) .  The amount of RNA loaded Is vlsuallzed by 
the ethidium bromlde stalnlng of the 28 S rRNA (c). 
2.7-kb HLA-E transcript was obtained, RNA isolated 
from IFN-y-induced K562 cells was used to  investigate 
possible  differences  in the coding regions of the two HLA- 
E transcripts by S1  nuclease mapping. K562 cells stim- 
ulated  for 48 h  with 1000 U/ml  IFN-y showed high and 
equal amounts of both HLA-E messages, but only low 
level of  HLA-B  mRNA (Fig. 5A). Two overlapping  probes 
derived from the cDNA clone LG2-Cl, covering the  se- 
quence coding for the leader up to the end of the a3 
domain, were  used (Fig. 5B). Only a single  band of the 
expected  size was detected  with either of the two probes 
in K562 RNA, demonstrating that both HLA-E tran- 
scripts  are identical in  the 5' portion (signal  sequence up 
to the 3'end of exon 4). The bands were shown to be 
specific for HLA-E, because they are not protected in 
HLA-B27'X63 transfectants. Identity of the 3' portion of 
the HLA-E transcripts  was confirmed by  PCR amplifica- 
tion,  using  primers located in exon 4 and  the 3' UT (Fig. 
6). HLA-E  mRNA isolated from the L cell and X63 trans- 
fectants.  the  human cell lines K562, Jurkat, LC2 and  the 
human  tissues,  spleen, liver, thymus,  and  placenta gave 
rise to the  same amplification product of the expected 
size of 447 bp (Fig. 6). These  results  demonstrate  that 
the two HLA-E transcripts code for the  same polypeptide 
and differ  only in the  extent of the 3' untranslated region. 
Dqferential  regulation of two HLA-E mRNA spec ies .  
Interestingly, two AUUUA motifs that confer  instability 
to the mRNA  of certain lymphokines and oncogenes, 
including  c-fos  (29. 30). are located downstream of the 
first two  immediately  adjacent polyadenylation signals  in 
the HLA-E gene  and  are  present only in the large tran- 
script (Fig. 4). Thus, it was conceivable that a rapid 
degradation  specifically of the 2.7-kb mRNA in  activated 
cells,  directed by this  element, might explain the preva- 
lence of the 1.8-kb HLA-E mRNA upon stimulation. To 
test  this possibility, PBL were activated with PHA in the 
presence  or  absence of the inhibitor of protein synthesis, 
CHX, which  leads to the stabilization of  mRNA molecules 
sensitive to this specific degradation. Inasmuch as the 
two HLA-E transcripts share the same transcriptional 
start point, differential regulation at  the level of tran- 
scription initiation that might equally be affected by 
CHX, can be ruled out. As shown in Figure 7A. CHX 
increases the steady-state levels of both HLA-E tran- 
scripts. Similarly, c-fos mRNA, investigated as positive 
control, accumulates drastically upon PHA/CHX treat- 
ment  because CHX prevents the  enhanced degradation 
of c-fos mRNA during prolonged stimulation (29). The 
same result was obtained with Jurkat cells. Increased 
levels of both HLA-E transcripts upon 12-0-tetradeca- 
noylphorbol 13-acetate/PHA  stimulation  were further 
amplified by CHX treatment. without  affecting  the  ratio 
of the two messages (data not shown). Therefore, we 
conclude that differences  in  stability of the two HLA-E 
transcripts do not  account  for the prevalence of the 1.8- 
kb mRNA upon  stimulation. 
CELL SURFACE  EXPRESSION  OF HLA-E ANTIGEN 2949 
EXON 4-Alpha 3 EXON  5-Transmembrane 
1 A TAC ACG  TGC CAT GTG  CAG CAT GAG  GGG  CTA CCC GAG  CCC GTC ACC  CTG  AGA  TGG  A E CCG  GCT  TCC  CAG  CCC 
Tyr Thr  Cys His Val  Gln His Glu  Gly  Leu  Pro  Glu  Pro  Val Thr Leu  Arg  Trp  Lys  Pro  Ala  Ser  Gln  Pro 
2 57 274  275   280  
7 4  ACC  ATC  CCC  ATC  GTG  GGC  ATC AT  GCT  GGC  CTG TT CTC CTT GGA TCT  GTG  GTC  TCT  GGA GCT GTG  GTT GCT GCT 
Thr Ile Pro  Ile  Val  Gly  Ile  Ile  Ala  Gly  Leu  Val Leu Leu  Gly  Ser  Val  Val  Ser  Gly  Ala  Val  Val  Ala  Ala 
2 8 1   2 9 6   3 0 5  
EXON 6-Cyt0 1 EXON 7-Cyto 2 
1 4 9  GTG ATA  TGG  AGG  AAG  AAG  AGC  TCA  G a GGA  AAA  GGA  GGG  AGC TAC TCT  AAG GCT GAG  T  AGC  GAC  AGT  GCC 
Val Ile Trp  Arg  Lys  Lys  Ser Ser Gly  Gly  Lys  Gly  Gly Ser Tyr  Ser  Lys  Ala  Glu Trp Ser  Asp  Ser  Ala 
306   313   314   324   325   329  
EXON 8 
2 2 1  CAG  GGG TCT GAG TCT CAC  AGC  TTG  TAA  AG CCTGAGACAGCTGCCTTGTGTGCGACTGAGATGCACAGCTGCCTTGTGTGCGACTGAGAT 
Gln Gly Ser Glu Ser His Ser Leu * 
3 3 0   3 3 7  
3 1 1  
4 1 1  
511 
611 
7 1 1  
8 0 9  
907 
1007 
1107  
1 2 0 7  
1307  
1 4 0 7  
1507 
1607  
1705 
1805 
1 9 0 5  
GCAGGATTTCCTCACGCCTCCCCTATGTGTCTTAGGGGACTCTGGCTTCTCTTTTTGCAAGGGCCTCTGAATCTGTCTGTGTCCCTGTTAGCACAATGTG 
AGGAGGTAGAGAAACAGTCCACCTCTGTGTCTACCATGACCCCCTTCCTCACACTGACCTGTGTTCCTTCCCTGTTCTCTTTTCTATTA~TAAGAAC 
CTGGGCAGAGTGCGGCAGCTCATGCCTGTAATCCCAGCACTTAGGGAGGCCGAGGAGGGCAGATCACGAGGTCAGGAGATCGAAACCATCCTGGCTAACA 
CGGTGAAACCCCGTCTCTACTAAAAAATACAAAAAATTAGCTGGGCGCAGAGGCACGGGCCTGTAGTCCCAGCTACTCAGGAGGCGGAGGCAGGAGMTG 
GCGTCAIYCCCGGGAGGCGGAGGTTGCAGTGAGCCAGGATTGTGCGACTGCACTCCAGCCTGGGTGACAGGGTGAAACGCCATCTCAAAA AATAAA AAT 
TAAAA A A T ~  AAAAGAACCTGGATCTCATTTTTCATATTCTTGCAATGAAATGGACTTGAGGAAGCT~GATCATAGCTAG~TACAGAT 
AATTCCACAGCACATCTCTAGC~~~~GCCTATTCCTATTCTCTAGCCTATTCCTTACCACCTGTAATCTTGACCATATACCTTGGAGTTGAATATTG 
TTTTCATACTGCTGTGGTTTGAATGTTCCCTCCAACACTCATGTTGAGACTTAATCCCTAATGTGGCAATACTGAAAGGTGGGGCCTTTGAGATGTGATT 
G G A T C G T A A G G C T G T G C C T T C A T T C A T G G G T T A A T G G A T T C T G A G C  
TAGCATGCCCAOCCCACAGAGAGCCTCCACTAGAGTGATGCTAAGTGGAAATGTGAGGTGCAGCTGCCACAGAGGGCCCCCACCAGGG~TGTCTAGTG 
TCTAGTGGATCCAGGCCACAGGAGAGAGTGCCTTGTGGAGCGCTGGGAGCAGGACCTGACCACCACCAGGACCCCAGAACTGTGGAGTCAGTGGCAGCAT 
GCAGCGCCCCCTTGGGAAAGCTTTAGGCACCAGCCTGCAACCCATTCGAGCAGCCACGTAGGCTCGACCCAGCAAAGCCACAGGCACGGGGCTACCTGAG 
GCCTTGGGGGCCAATCCCTGCTCCAGTGTGTCCGTGAGGCAGCACACGAAGTCAAAAGAGATTATTCTCTTCCCACAGATACCTTTTCTCTCCCATGACC 
CTTTAACAGCATCTGCTTCATTCCCCTCACCTTCCCAGGCTGATCTGAGGTAAACTTTGAAGTAA ATAAA AGCTGTGTTTGAGCATCATTTGTATTT 
CATTTGTGCGTTTTGTGCCTTGTTGTTTTAATTTTTTAACCACATTCAAGCTATCCTTTGGCTTCCAATGCCATGGTCCACCCAGAACTGCATTCACTGG 
CCCGTGTTCTAGTTCTGGTCATGCCGACTTTCCCGTTTTCCTGGTGAATCCCTGT~TCACCTGAGTCTCATTCTGTCAGGTGATATCCAGTAAGAAGGC 
AACATGTGCGGTGAGAAAGCCCAGGGAGTCCTGGGTGTGAATTTTTACTTTGCCATTTCTTCCTGTGTGTACACGCGGTGGGGCTTCACCTGTCTGAGCTC 
of the protein coding region is given in  triplets with the amino acid sequence below in  the  three  letter code. The  exons  and  corresponding  protein 
FLgure 4. Nucleotide and deduced amino  acid sequence of the large HLA-E transcript  and  the 3’ portion of the HLA-E gene.  The nucleotide sequence 
domains  are  indicated  above  the  sequence  wlth  spacing  between  individual  exons.  The  numbers of the  amino  acids  are  shown  for  the  first  and  the 
last  residue of each exon and  start wlth  Tyr. the  first  amino acld encoded by LG-El . The nucleotide numbering  indicated on the left corresponds  to 
the cDNA sequence  contained  in LG2-E1 up to the C at position 1695  and  continues  up to the Sac1 site  with the genomic  sequence derived from the 
cd3.14 HLA-E gene.  The  sequences of the  3’ portion of cd3.14 and of LG2-E1 are colinear  and  identical. except for  a  substitution (A for G )  at position 
mRNA instability  to  oncogene  and  cytokine  trancripts  are  shaded. The  beginning of each exon I s  underlined. cDNA clone LG2-E2 codes for the 
1218  and a  deletion at  position 1580  in  LG2-El  (indicated by  bold type]. Polyadenylation signals  are  underlined. AUUUA motifs reported  to  confer 
sequences 848 to  1557 bp. (These  sequence  data  are  available  from EMBL under  accession  number  X64879.) 
Expression of HLA-E Ag upon DNA transfer into 
mouse cell lines. Inasmuch as  no HLA-E specific mAb is 
available, we used mouse cell lines to address  the  ques- 
tion  whether HLA-E encodes a cell surface protein. Ini- 
tially, mouse L cells expressing human Pzm (527,  (14)) 
were transfected  either  with  the cosmid cd3.14 or with 
the cDNA construct pLG2-C1/KSVneo. encoding the 1.8- 
kb HLA-E  cDNA,  LG2-C1 , with a HLA-B8-derived leader 
sequence. Unrearranged integration of the input DNA 
was confirmed by Southern blot analysis. All transfec- 
tants tested transcribe  the HLA-E gene  predominantly in 
a 1 .8-kb mRNA (Fig. 8B), but no cell surface expression 
of an  HLA class I H chain could be detected (Fig. 9). The 
same negative results were obtained on cotransfection of 
either HLA-E construct, together with the  human &m 
gene,  into  mouse  P8 15 cells. 
In contrast, cotransfection of the cd3.14 cosmid and 
the  human pzm gene  into the mouse myeloma cell line 
P3X63Ag8.653 (X63)  resulted  in a reproducible low  level 
of cell surface expression of an HLA class I H chain in 
six  independently isolated X63 transfectant clones, 
which  transcribed  both  the  human p2m and  the HLA-E 
genes (Figs. 8a and 9). Moreover. a transfectant clone 
receiving only HLA-E DNA also showed cell surface 
expression.  Surface staining could be detected with all 
HLA-class I specific antibodies used: Al.4, BQ. 12.1 (Fig. 
9). and TM3. W6/32 reacted already strongly with the 
single X63/human Pzm transfectants  and was not used 
in  further  analyses. The cell surface expression was poor 
in all transfectants irrespective of the  amount of  HLA-E 
mRNA present and  was much lower than  the HLA-B27 
staining  when  transfectant clones expressing  similar lev- 
els of HLA-class I mRNA were compared (Figs. 5A, 8a, 
and 9). The cell surface expression of an HLA-E a-chain 
complexed with &m was confirmed by labeling mem- 
brane proteins with Iz5I in lactoperoxidase-catalyzed re- 
actions  and  subsequent  immunoprecipitation  with  either 
BBM.l or A1.4 (Fig. lo), detecting  a 42-kDa H chain  in 
the HLA-E transfectants. In agreement  with the  staining 
of the  transfectants by indirect  immunofluorescence, the 
amount of labeled HLA-E encoded H chain was much 
lower than  that of the HLA-B27 a-chain in the corre- 
sponding transfectant. Immunoprecipitation of metabol- 
ically labeled X63-transfectants also showed that the 
amount of labeled HLA-E encoded H chain was much 
lower than  that of the HLA-B27 a-chain  (which  contains 
the  same  number of methionine  residues as the HLA-E 
polypeptide) in the corresponding transfectant, indicat- 
ing that  the low  HLA-E cell surface expression is due  to 
reduced levels of  HLA-E polypeptide within the cell (30a). 
c- hu RZm 
6 
Figure 5. A. Chararterlzatlon of the RNA preparations  used  in  the SI 
nuclease  protertlon  assays. A total of 15 p g  of total RNA Isolated from 
HI,A-H27/human dlm'X63 transfertants (lane 1): HLA-R27' X 6 3  trans- 
fertants [lane 2):  untransferted X 6 3  rells (lane 3): IFN-7- stimulated 
[lane 4 )  and  unstlmulated K562 cells (lane 5 ) :  HeLa rells (lane 6 ) :  R27 
homozygous R cell line LC2 [lane 7 )  were  tested by Northern blot analysis 
for  the  expresslon of the HLA-E gene ( fop.  hybridlzatlon  with  oLC2-Cl). 
the expresslon of the HLA-R locus and  human Jzm [middle. hybrldlzatlon 
wlth  the H sperlflr and a human prim probe).  The  amount of RNA loaded 
was rontrolied by ethidium  bromlde  stalnlng of the 18 S rRNA (borfom). 
€3. S1  nuclease  protertlon  assays. Upper panel. The orlgln of the  rontin- 
uously labeled overlapplng  single-stranded  antlsense  probes is shown. 
The locatlon and  sequence of the  prlmers  and  the  restrlrtlon sltes used 
in the PCR generatlon of the  probes  with  the rDNA LC2-CI in pUC18 as 
overlaps wlth  the  sequence of the  LC2-El rDNA. Lower panel. l e f f :  The 
template are  represented. Note that  the  404 nurleotlde  exon  3/4 fragment 
534 nucleotlde probe roverlng exon 1 to 3 and 40 nurleotldes of the 
pUCl8  polyllnker (boxed in upper panel)  (lanes 1 and 8) was hybrldlzed 
to total RNA from elther  the HLA-R27' X 6 3  transfertant (lanes 2. 4. and 
6 )  or K562  stlmulated  wlth 1000 U/ml IFN-7 for 48 h [fanes 3. 5.  and 7). 
dlgested wlth 600 U [lanes 2 and 3). 1200 U [lanes 4 and 5) .  or  2400 U 
[lanes  6 and  7) of SI nuclease at 3 2 T  for  2  h.  run  on a 4% arrylamide/ 
7 M urea gel. and  autoradlographed. Lower panel.  righf: The  404  nucleo- 
tide  probe  represcntlng  exon 3 and 4 (lanes 1 and 8) was hybrldlzed lo 
total RNA from  either  the H27* X 6 3  transfertanl (lanes 2. 4. and 6 )  or 
stimulated [see above) K562 [lanes 3. 5. and 7 ) .  dlgested with 600 U 
(lanes 2 and 3). 1200 U (lanes 4 and 5) .  or  2400 U [lanes 6 and 7) of SI 
nuclease at 32°C for 2 h. run on a 4'; acrylamldc/7 M urea gel. and 
auloradiographed.  The  bands  derived  from B27'X63 rells [lanes 2.4.  and 
6 )  represent most likely protected  sequences of exon  4  that  are  conserved 
bctween HLA-R27 and HLA-E. Addlllonal slze standards were  generated 
by restrlrtlon of the probe  after PCR ampllflratlon  wlth Bgfll (lane 9) or 
double-stranded DNA and  ran be cleaved by the restrlction  enzymes. 
Psfl [lane 10). Note that  due lo PCR generallon only 10% of the probe Is 
No HLA n-chains could be immunoprecipitated from cul- 
ture  supernatants. 
DISCUSSION 
Previous  reports on the  transcription of the HLA-E gene 
used probes  from the 3' untranslated region of the HLA- 
E gene that either cross-react with HLA-A. -B. and -C 
transcripts  (4. 5 .  12) or hybridize exclusively to the large 
transcript (4. 31,  12). We used an oligonucleotide that is 
strictly HLA-E specific and  detects both transcripts,  and 
could show that  the  ratio between the two  messages is 
variable in different  tissues  and is related to cell activa- 
tion in vitro. 
The  differential  and tissue-specific regulation of the 
two HLA-E transcripts led us to  determine  the  nature of 
the  2.7-kb mRNA.  cDNA sequence  analysis. S1 nuclease 
protection assays and PCR cDNA amplification  showed 
that both transcripts have identical protein coding se- 
" 
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Figure6. PCR ampliflratlon of a region roverlng the 3'end of exon  4 
to the 3' UT of the HLA-E  mRNA. a. Locatlon and  sequence of the  primers 
b. 2 p g  of total RNA from the indicated rells were  used  for  first-strand 
PI and P2 used for  ampliflcatlon of the 3' portlon of the HLA-E  mRNA. 
rDNA synthesls. A total of 50 ryclesof PCH ampllfirallon  was  rarrled out 
with the PI and P2  prlmers on 1/30 of the cDNA reacllon mlx prepared 
6 )  transfected human &m' I. rells. untransferted  human d m '  L cells 
from  pLC2-CI/KSVneo [larw 3) and  three  independent  cd3.14 (fanes 4- 
[lane 7 ) .  two  Independent  rd3.14/human d2m transferrted X 6 3  clones 
[lanes 8 and 9). a human &m/H27' X 6 3  transfertant  clone [lane 10). 
resting [lane 12). and IFN-7-stimulated (lane 11 ) K562 cells. unstimu- 
lated LC2 cells (lane 13). untreated (lane 15). and 12-0-tetradecanoyl- 
phorbol 13-aretate/PHA-stlmulated (lane 14) Jurkat rells and  the follow- 
lng human tissues: thymus (lane 16). spleen (lane 17). placenta [lane 
18) and llver [lane 19). Sperifirlty of the  447-bp  ampliflratlon product 
coding for a 3' unspllced HLA-E mRNA segment  was  ronflrmed by hy- 
bridizatlon  wlth an  ollgomer speriflr  for  the  transmembrane reglon 15'- 
ACA CAC CAC ACA TCC AAC GAG A-3') of HLA-E mRNA [data not 
shown).Onepgofeitherrd3.14[lane1)orLG2-CI (lane2)wereampllfied 
to exclude  rontaminallon  wlth DNA and  demonstrate  speclflrity.  respec- 
tively. 
quences  and  differ only in the  extent of the 3' untrans- 
lated region. The differential  expression of the two HLA- 
E mRNA species is controlled by alternative polyadenyl- 
ation.  The  use of alternative polyadenylation signals in 
the 3' untranslated region has also been described for 
transcripts of Tla genes in the mouse (32. 33). but its 
significance  with  regard  to  thymus leukemia Ag expres- 
sion is not known. Moreover. the  mechanisms controlling 
alternative poly(A) site usage are  also not yet well under- 
stood (34). Interestingly. only recently a role of the 3' 
untranslated region in the control of translation effi- 
ciency has become apparent (30). It has been shown  that 
downstream  elements  in  cytokine  transcripts  are  capable 
of suppressing  their  translation (35. 36). 
Conflicting results  concerning HLA-E cell surface 
expression  have been reported (3. 8). and  the possibility 
remained that  the lack of surface expression of the HLA- 
E H chain upon  transfection  into  the  human B-LCL.221 
might be the  result of the  mutant phenotype of this cell 
line, or due to the  transfection of the HIndIII subclone 
that only  encodes the  short  1.8-kb HLA-E transcript  (3). 
Initially, we transfected both an eucaryotic expression 
construct of the HLA-E  cDNA LC2-C 1. which  should only 
result  in the  synthesis of the  1.8-kb HLA-E transcript, 
and the cosmid cd3.14 that also codes for the 2.7-kb 
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of IO pg of total RNA per  lane  isolated  from  either  resting PBL or PBL 
Flgure 7. A. Induction and  stability of HLA-E mRNA in PBL. A total 
after PHA or PHA/CHX treatment, respectively. was fractionated on a 
mer c-fos/ol (left] or with the 33 mer oLG2-Cl (right). E. Differential 
formaldehyde  agarose gel and hybridized either  with  the  c-fos-specific 60 
induction of both HLA-E transcripts  in  SW480 by IFN-y. A total of 10 pg 
of total RNA per  lane  isolated  from  unstimulated (lane 2) or IFN-y-treated 
a formaldehyde  agarose gel and hybridized with  oLG2-Cl.  The  amount of 
(lane 1 )  SW480  cells and  untreated LG2 cells (lane 3) .  was  separated on 
RNA loaded was controlled by ethidium bromide staining of the  28 S 
rRNA (bottom). 
transcript,  into  mouse cell lines.  Inasmuch as on trans- 
fection of the cosmid the  1.8-kb mRNA is mainly synthe- 
sized.  only it was  used in  later  experiments. Cell surface 
expression  was only observed after  transfection of the 
mouse myeloma cell line X63. This  result might  reflect 
genetic variations in MHC encoded transporter and/or 
proteasome genes that by controlling the endoplasmic 
peptide spectrum  influence  class I assembly and  thus cell 
surface  expression  (37-39).  Finally, we cannot exclude 
that  the failure to detect the HLA-E Ag in 527  and P815 
transfectants might be due to the broader  staining  and 
higher  nonspecific  antibody  binding  profiles of untrans- 
fected cells compared to X63  cells (Fig. 8) that could 
obscure a weak HLA-E signal. 
Recently, the  absence of cell surface  expression of Qa- 
2 Ag in L cells  transfected  with the Q7 and Q9 genes, 
was explained by the predominant  synthesis of alterna- 
tively spliced mRNA lacking exon 5 (40).  Therefore, we 
1 2 3 4 5 6  1 2 3 4 5  
r"'- 
L cell ( a )  and X63 (b )  transfectants. a .  1 5  p g  of total RNA from three 
Flgure 8. Detection of HLA-E and human &m mRNA in  human &m' 
representative  human p,m/E' X63  transfectant  clones (lanes 1-3). un- 
stimulated K562 (lane 4 ) .  LC2 (lane 5). and  untransfected  X63 (lane 6) 
were separated on a formaldehyde agarose gel and probed with either 
oLG2-CI (top) or the  human pzm probe (middle). Exclusively. the 1.8-kb 
HLA-E transcript is present  in  the  transfectants (lanes 1-3). All trans- 
was controlled by ethidium  bromide  staining of the 1 8  S rRNA (bottom). 
fectants  transcribe  human &m. Identity of the  amounts of RNA loaded 
&m+ L cell clones (lanes 1-3). untransfected  human &m+ L cells (lanes 
b. 15 pg of total RNA from three  independent  cd3.14-  transfected  human 
gel and probed either  with oLG2-Cl (top) or the  human Bzm probe (mld- 
4 and 5). and LC2 cells (lane 6) were  separated on a  formaldehyde  agarose 
dle). Human  pZrn/E+ L cells  transcribe  mainly  the  1.8-kb HLA-E  mRNA. 
A 2.7-kb  signal is visible due  to  overexposure as can be estimated from 
the  intensity of the HLA-E signals in LG2 (lane 6). The  amount of RNA 
loaded was  controlled by ethidium bromide stalning of the  18 S rRNA 
(bottom). 
also  asked  whether a similar  mechanism might lead to 
the secretion of the HLA-E molecule. PCR amplification 
demonstrates that all transfectants express the same 
HLA-E mRNA, containing exon 5 (Fig. 6). and confirm 
our  previous  finding that all HLA-E transcripts code for 
the  same H chain. Moreover, no HLA class I H chain  was 
detected  in culture  supernatants of the  transfectants. 
The  absence  or low levels of intracellular  and cell sur- 
face  expression of the HLA-E H chains in all transfectant 
clones,  irrespective of the  amount of  HLA-E  mRNA pres- 
ent. might be explained by a low translation efficiency 
and/or  inadequate  assembly  and  transport of the HLA-E 
molecule in the mouse cell lines.  Accumulating  evidence 
suggests that  the  synthesis of a class I polypeptide is not 
the only requirement  for cell surface expression of the 
class I transplantation Ag, but that additional factors  are 
necessary which control processing and intracellular 
trafficking  in a cell type and locus/allele-specific manner 
(37,38. 41-43). It is conceivable that  the  same  or  similar 
mechanisms regulate cell surface transport of HLA-E 
molecules. The  inefficient cell surface  transport is not 
likely to be due to the HLA-E leader  peptide,  because the 
cDNA construct pLG2-C 1 /KSVneo that codes for an HLA- 
B8 leader  peptide is not  expressed at  the cell surface.  The 
cell surface expression of the HLA-E Ag in the X 6 3  
transfectants  indicates  that  the HLA-E Ag might be a cell 
surface molecule in vivo. After  transfection of the HLA- 
E gene into mouse cell lines, the 1.8-kb transcript is 
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log fluorescence 
Flgure 9. Binding of the mAb directed  against HLA class 1 n-chains  (A1.4). HLA class I complexes (B9.12.1). H-2Dd (34-4-21s). H-2K" (141-1 1). 
and  human &m (BBM.1) to  X63  and  human &m' L cell (527)  transfectants.  Each  diagram of the  upper  row (a-d) compares  the  binding of the 
indicated  antibody  to human &m'. human B,m/HLA-E'. and  human B2m/HLA-B27' X 6 3  transfectants. In the  lower  row  each  diagram  [e-g)  compares 
the  staining  with  the  indicated  antibody of the  human  &m-  expressing L cell to that of its HLA-E transfectant. For X 6 3  cells mAb 34-4-21s  was 
used to determine H-2Dd expression. In the  case of the L cell transfectants. H2-K" expression was  assessed  with mAb 141 - 113. 
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Flgure 10. lmmunopreclpitation of iodinated cell surface HLA class I 
H chains.  Lysates of labeled human &m' (lanes 1 and 2). human  &m/ 
B27' (lanes 3 and  4).  and  human  &m/E+  (lanes 5 and 6) X 6 3  transfec- 
tants were  sequentially  immunoprecipitated  with mAb: isotype  control, 
anti-  human CD4. M-T242: anti-human  class I H chain. A1.4 (lanes  2.4. 
and 6). and finally anti-human 8,m. BBM.1 (lanes  1.3.  and 5). Analysis 
was performed by 10% SDS-PAGE (lanes 1-4  were exposed for  7  days 
and  lanes 5 and 6 for  10  days). BBM.1 also  precipitates  mouse  class I 
molecules complexed with human &m from all X 6 3  transfectants  (lanes 
I H chains lh the BBM.1 immunoprecipitate (lane 5). The presence of 
I .  3. and 5). A faint HLA-E-derived a-chain is visible below the H-2 class 
human  class I a-chains in the  transfectants  reduced complex formation 
of human b2rn with  endogenous H-2 class I H chains. 
mainly  synthesized and only a low amount of intracellu- 
lar  and cell surface HLA-E class I molecule is detected. 
Inasmuch as  differential regulation of the two transcripts 
was  demonstrated in vivo, the possibility remains  that 
only the  2.7-kb HLA-E transcript leads to efficient trans- 
lation and cell surface expression of HLA-E Ag due to 
genetic  elements  responsible for posttranscriptional  con- 
trol encoded by its extended 3' untranslated region. 
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